Patent · US Expired

Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability

US6348490B1 · kind B1 · utility

5Cited by

4References

4Claims

0Family size

Assignee

Asta Medica Aktiengesellschaft · DE

Inventors

Helmut Hettche · Dietzenbach, DE
Matthias Rischer · Frankfurt am Main, DE
Werner Sarlikiotis · Bielefeld, DE

Key dates

Filing date	Aug 20, 1999
Grant date	Feb 19, 2002
Priority date	—
Expiry date	Aug 20, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4858
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel, advantageous dosage forms of thioctic acid and the enantiomers thereof together with thioctic acid salts are described. The pharmaceutical formulations according to the invention are used for the production of pharmaceutical dosage forms which release the active ingredient more rapidly and have greater bioavailability than previous forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.